Fibroblast Growth Factor 23, Cardiovascular Disease, and Inflammation

被引：4
|
作者：
Stern, Leonard [1 ]
机构：
[1] Columbia Univ, Med Ctr, Dept Med Nephrol, New York, NY 10032 USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 7卷 / 07期
关键词：
MORTALITY; EXPRESSION; RISKS; BONE;
D O I：
10.2215/CJN.05500512
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1061 / 1062
页数：2
相关论文
共 50 条
  • [31] New insights into the role of fibroblast growth factor 23 in cardiovascular disease in type 2 diabetics
    Silva, Ana Paula A.
    Pinho, Ana
    Fragoso, Andre
    Sousa, Pedro
    Santos, Nelio
    Silva, Claudia
    Tavares, Nelson
    Faisca, Marilia
    Jesus, Ilido
    Neves, Pedro
    CIRCULATION, 2012, 125 (19) : E903 - E903
  • [32] Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults
    Paul, Shejuti
    Wong, Mandy
    Akhabue, Ehimare
    Mehta, Rupal C.
    Kramer, Holly
    Isakova, Tamara
    Carnethon, Mercedes R.
    Wolf, Myles
    Gutierrez, Orlando M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (16):
  • [33] Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?
    Filler, Guido
    McIntyre, Christopher
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (02) : 146 - 148
  • [34] Fibroblast growth factor 23
    Smith, Edward R.
    McMahon, Lawrence P.
    Holt, Stephen G.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (02) : 203 - 227
  • [35] Fibroblast growth factor 23/Klotho system in the context of cardiovascular damage
    Donate-Correa, Javier
    Muros-de-Fuentes, Mercedes
    Mora-Fernandez, Carmen
    Navarro-Gonzalez, Juan F.
    MEDICINA CLINICA, 2013, 140 (09): : 420 - 423
  • [36] Fibroblast Growth Factor 23 and Cardiovascular Outcome in Acute Kidney Injury
    Onofrei, Simona Daniela
    Radulescu, Daniela
    Peride, Ileana
    Niculae, Andrei
    Checherita, Ionel Alexandru
    REVISTA DE CHIMIE, 2019, 70 (04): : 1268 - 1271
  • [37] Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
    Baia, Leandro C.
    Humalda, Jelmer K.
    Vervloet, Marc G.
    Navis, Gerjan
    Bakker, Stephan J. L.
    de Borst, Martin H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (11): : 1968 - 1978
  • [38] The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
    Pastor-Arroyo, Eva-Maria
    Gehring, Nicole
    Krudewig, Christiane
    Costantino, Sarah
    Bettoni, Carla
    Knopfel, Thomas
    Sabrautzki, Sibylle
    Lorenz-Depiereux, Bettina
    Pastor, Johanne
    Strom, Tim M.
    de Angelis, Martin Hrabe
    Camici, Giovanni G.
    Paneni, Francesco
    Wagner, Carsten A.
    Rubio-Aliaga, Isabel
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 49 - 59
  • [39] Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?
    Peiskerova, M.
    Kalousova, M.
    Kratochvilova, M.
    Dusilova-Sulkova, S.
    Uhrova, J.
    Bandur, S.
    Malbohan, I. M.
    Zima, T.
    Tesar, V.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (04): : 276 - 283
  • [40] Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in theEVOLVEtrial
    Block, Geoffrey A.
    Chertow, Glenn M.
    Cooper, Kerry
    Xing, Shan
    Fouqueray, Bruno
    Halperin, Marc
    Danese, Mark D.
    HEMODIALYSIS INTERNATIONAL, 2021, 25 (01) : 78 - 85
12345